about
ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancersHeme controls the regulation of protein tyrosine kinases Jak2 and SrcUNC119a bridges the transmission of Fyn signals to Rab11, leading to the completion of cytokinesisTransactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future ResearchThe molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targetsPhosphoregulation of the WAVE regulatory complex and signal integrationSRC: marker or actor in prostate cancer aggressivenessSmooth muscle tension induces invasive remodeling of the zebrafish intestineThe importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistanceRegulation of SRC family kinases in human cancersMetastasis suppressor genes at the interface between the environment and tumor cell growthThe blood-testis barrier and its implications for male contraceptionGefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplificationBMP-7 enhances cell migration and αvβ3 integrin expression via a c-Src-dependent pathway in human chondrosarcoma cellsIdentification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesDivergent modulation of Src-family kinase regulatory interactions with ATP-competitive inhibitors.Overexpression of atypical protein kinase C in HeLa cells facilitates macropinocytosis via Src activationTyrosine phosphorylation of cortactin by the FAK-Src complex at focal adhesions regulates cell motilityRole of Src kinases in mobilization of glycosylphosphatidylinositol-anchored decay-accelerating factor by Dr fimbria-positive adhering bacteria.Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.Pseudomonas aeruginosa interacts with epithelial cells rapidly forming aggregates that are internalized by a Lyn-dependent mechanism.Tyr724 phosphorylation of ELMO1 by Src is involved in cell spreading and migration via Rac1 activation.Novel small molecule inhibiting CDCP1-PKCδ pathway reduces tumor metastasis and proliferation.Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER⁺ Breast Cancer Cells.Significance of talin in cancer progression and metastasis.C-Src-mediated phosphorylation of δ-catenin increases its protein stability and the ability of inducing nuclear distribution of β-catenin.PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasionSignificance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.C-Src and c-Yes are two unlikely partners of spermatogenesis and their roles in blood-testis barrier dynamics.SRC: a century of science brought to the clinic.CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancerSystems microscopy approaches to understand cancer cell migration and metastasis.Src inhibitors in the treatment of metastatic bone disease: rationale and clinical dataKAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancerMetastatic bone disease: role of transcription factors and future targets.Oncogenic Src requires a wild-type counterpart to regulate invadopodia maturation.Differential requirement for Src family tyrosine kinases in the initiation, progression, and metastasis of prostate cancerCD24 induces expression of the oncomir miR-21 via Src, and CD24 and Src are both post-transcriptionally downregulated by the tumor suppressor miR-34a.Diacylglycerol kinase α promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src.Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study
P2860
Q24303562-FAA9EA71-DE61-472E-AC09-17E5066C8496Q24305018-CB59D648-7F41-47B8-B47B-F359030DA113Q24337437-EAE81513-9F69-4042-A9FB-234EAE144439Q26771727-063AF2A8-CADD-4E39-AB06-21FC4DD114F0Q26782593-CE85C60A-EB33-476F-80D4-AE7435A50454Q26863403-17BF63B9-BE57-41CA-9C98-649ED1D36748Q27012541-683B3AA8-CAF3-4774-A85A-4C42B7937195Q27318726-7A4F6113-1317-4F30-B373-2352920C8B59Q28076745-3165E8B1-98BE-4DFD-88B6-310EA2806F7CQ28243770-7215E20A-1B45-446D-9EB7-68D793BCE2B1Q28394526-99D05559-9F8A-4B44-BE7E-747E4959F9A3Q28395237-5A30822F-F077-4E9B-AB7D-97B4D5996974Q28534577-7B02FFAE-7BC4-40E5-827D-AC97208526B4Q28544902-43DF3C32-97FD-43B3-BF30-7E0D6EE3C827Q29617680-6F895675-5CAA-47B8-853A-C539C2ECFB73Q30009417-455C4E4E-88FF-4E28-9E7E-B8C7237300FBQ30009453-82F1003F-4112-4AAB-A17F-89571E910ECDQ30010209-49F8D7CC-E669-4278-9062-4C5D60629CEBQ30155574-67820718-44CB-43C4-B1B6-0448D4DDC146Q30416923-C173EE63-F8D3-4516-BA6A-98F946A25439Q30555799-61A9270C-41B3-46D2-AD3D-A404F086B5BEQ30658863-3363ABB4-5C08-47C7-AAC7-1052D51FB1A8Q33738983-9F7C86E1-9778-4FE1-B3AB-F8B3EFA02966Q33754877-8E7A22A2-7667-4BFF-A0AE-835A1AFA9868Q33763551-DED0A600-25E0-45BB-94FC-96E67029FD5CQ33817799-813F1D34-4140-463E-B3F8-8EE871387E28Q33872677-2B852482-6881-43E7-8B1F-6D987FE5F520Q33888946-8EDFFC73-82BF-4CC0-A224-72372651D721Q33966470-C05D58C9-1756-4864-8FC6-ECC20CCD7914Q34041298-8F4C3050-9B6F-4BB4-A543-711D41051A37Q34091227-535E064A-13CD-425E-A80E-B750140D0DF1Q34106013-69CB4B3F-8EBF-49F0-9BD3-3D71D6B74667Q34182834-6BCB6FE7-C7C1-4069-97AF-0FC6B71CC498Q34184870-27ED0779-6E63-4C64-ABD5-82838DDD7FDEQ34217531-3C925D02-FAB2-47D6-8870-E33339D80319Q34273690-D549B6A3-9DBF-4D05-A2BD-9E92DF15673FQ34364815-DB441C03-53B9-4E28-883E-331F35A47600Q34637872-8C527CB0-1612-426F-AF73-A55279EB3081Q34654588-315C23DE-A7FB-44F8-8C35-1057DD0391C5Q34658293-742EE948-92B2-4A8B-A0D8-EAE6F0FF3DA4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Src signaling in cancer invasion.
@en
Src signaling in cancer invasion.
@nl
type
label
Src signaling in cancer invasion.
@en
Src signaling in cancer invasion.
@nl
prefLabel
Src signaling in cancer invasion.
@en
Src signaling in cancer invasion.
@nl
P2860
P356
P1476
Src signaling in cancer invasion.
@en
P2093
Marcello Guarino
P2860
P356
10.1002/JCP.22011
P577
2010-04-01T00:00:00Z